Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization

NCT04312009 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04312009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
April 13, 2020
Completion date
February 1, 2021
Enrollment
205 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, corona virus infection, sars-cov infection